Clinical Trial Update: Efficacy Study of Δ9-THC to Treat Chronic Abdominal Pain [Phase 2]

View source ↗

Summary

This entry reports the completion of a Phase 2 efficacy study evaluating delta-9-tetrahydrocannabinol for chronic abdominal pain associated with chronic pancrea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• Delta-9-tetrahydrocannabinol (tetrahydrocannabinol (THC))

Snippet

Sponsor: Radboud University Medical Center | Conditions: Cannabinoid, Tetrahydrocannabinol | Phase 2 | Status: COMPLETED